Kate Zhong In The News
AARP Washington State Podcast
In our new Caring For Caregivers Conversation, brain health expert Dr. Kate Zhong joins our state director Marguerite Ro to talk about advances in Alzheimers treatment and what you can do to protect your brain. Dr. Zhong is a geriatric psychiatrist and founder of the Brainnovation Initiative at 51³Ô¹ÏºÚÁÏ.
Northwest Asian Weekly
There are over 53 million caregivers in the United States, possibly closer to 60 million. These caregivers are of all ages—nearly half are millennials or younger—and the people they care for come in all varieties. In spite of this, caregivers, and those they care for, are something of an invisible group. They are subjected to stereotypes of what a caregiver is, or who receives care, and they often feel alone. For these reasons, it’s important that caregivers also take care of themselves.
AARP Washington State Podcast
AARP Washington, BECU, and KING 5 hosted a free event to celebrate and support those who provide care for others at Town Hall Seattle. MSNBC news anchor, filmmaker and author Richard Lui cared for his father with Alzheimers over the last decade and he's become a passionate advocate for family caregivers. Dr. Kate Zhong, geriatric psychiatrist and founder of the Brainnovation Initiative at 51³Ô¹ÏºÚÁÏ gave practical advice and info on the latest in brain research. KING 5 Evening host Jim Dever moderated the discussion.
Northwest Asian Weekly
As the population ages and the demands of caregiving increase, discussions about caregiver wellness and brain health are gaining momentum nationwide. Approximately 38 million individuals across the country undertake the vital role of family caregivers, providing support for parents, spouses, adult children with disabilities, and other loved ones. Yet, the emotional and physical strains of caregiving cannot be understated.
King5
About 38 million Americans are caregivers for parents, spouses, adult children with disabilities, friends and other loved ones.
Chic Compass
Alzheimer’s patients and their loved ones have a renewed sense of hope now that the U.S. Food & Drug Administration approved the first Alzheimer’s drug in nearly two decades.